Methotrexate, blood pressure and markers of arterial function in patients with rheumatoid arthritis: a repeated cross-sectional study.

Mangoni, Arduino A; Baghdadi, Leena R; Shanahan, E Michael; Wiese, Michael D; Tommasi, Sara; Elliot, David; Woodman, Richard J

Mangoni, Arduino A; Baghdadi, Leena R; Shanahan, E Michael; Wiese, Michael D; Tommasi, Sara; Elliot, David; Woodman, Richard J.

Afiliação

Mangoni AA; Department of Clinical Pharmacology, School of Medicine, Flinders University and Flinders Medical Centre, Bedford Park, SA 5042, Australia.
Baghdadi LR; Department of Clinical Pharmacology, School of Medicine, Flinders University and Flinders Medical Centre, Adelaide, Australia.
Shanahan EM; Department of Rheumatology, Flinders University and Southern Adelaide Local Health Network, Adelaide, Australia.
Wiese MD; School of Pharmacy and Medical Sciences and Sansom Institute for Health Research, University of South Australia, Adelaide, Australia.
Tommasi S; Department of Clinical Pharmacology, School of Medicine, Flinders University and Flinders Medical Centre, Adelaide, Australia.
Elliot D; Department of Clinical Pharmacology, School of Medicine, Flinders University and Flinders Medical Centre, Adelaide, Australia.
Woodman RJ; Centre for Epidemiology and Biostatistics, School of Medicine, Flinders University, Adelaide, Australia.

Ther Adv Musculoskelet Dis ; 9(9): 213-229, 2017 Sep.

Article em En | MEDLINE | ID: mdl-28932292

Palavras-chave

asymmetric dimethylarginine; augmentation index; blood pressure; disease-modifying antirheumatic drugs; methotrexate; pulse wave velocity; rheumatoid arthritis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article